PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31236768-7	2019	Moreover, the blood level of tumor necrosis factor-alpha, interleukin-6, reactive oxygen species (ROS), and matrix metalloproteinase (MMP)-9 was decreased by tranexamic acid administration.	Tranexamic Acid	158-173	interleukin 6	Mus musculus	58-71	
30267577-6	2019	Furthermore, tranexamic acid treatment was observed to suppress increases in the plasma levels of matrix metalloproteinase-9 and interleukin (IL)-6, and skin expression of plasmin, CC chemokine 2, macrophages, signal transducer and activator of transcription (STAT)3, cyclin D and vascular endothelial growth factor (VEGF)-A that occurred in mice subjected to long-term UVA irradiation.	Tranexamic Acid	13-28	interleukin 6	Mus musculus	129-147	
30267577-7	2019	These results indicated that the nonmelanoma skin cancer induced by DMBA+UVA long-term irradiation is ameliorated by tranexamic acid through regulation of the plasmin/macrophage/IL-6/STAT3/cyclin D signal transmission pathway.	Tranexamic Acid	117-132	interleukin 6	Mus musculus	178-182	
35371322-6	2022	Furthermore, TA treatment suppressed the levels of carbohydrate antigen 125, interleukin-6, and tumor necrosis factor-alpha in the plasma.	Tranexamic Acid	13-15	interleukin 6	Mus musculus	77-90